Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) entered a license, distribution and supply agreement for Haemacure's proprietary fibrin and thrombin technology. The stock price climbed 34 cents to close at $1.89.
Angiotech Enters Licensing And Distribution Agreement
June 03, 2009 at 17:43 PM EDT
